Stock Taper 
ELDN
$3.20
▼ DOWN 3.61% (-0.12)
KEY STATISTICS
Market Cap$247.00 M
52w High$4.60
52w Low$1.35
Dividend Yield—
Frequency—
P/E-4.16
Volume1.01M
Shares Out.77.19M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
David-Alexandre C. Gros
COMPENSATION 2026
Salary$613,196
Stock Awards$268,660
Incentive Plan Pay$349,522
All Other Comp.$21,690
Total$3,216,148
ABOUT
SECTOR
Healthcare
WENT PUBLIC
September 17, 2014
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
33
PRICE TARGET
Target High$5.00
Target Low$5.00
Target Median$5.00
Target Consensus$5.00
UPCOMING EARNINGS
DateNov 13, 2026
DayFriday
Rev. Est.—
NOV
13
FRI
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2020-10-05 | Reverse | 1:18 |
| 2017-05-11 | Reverse | 1:9 |
PRICE
$3.20 ▼ DOWN 3.61% (−$0.12)About Eledon Pharmaceuticals, Inc.
https://eledon.com ↗Eledon Pharmaceuticals is a clinical-stage biopharma developing treatments for autoimmune diseases, ALS, and transplant patients, with lead candidate AT-1501 in Phase 2 trials for ALS and type 1 diabetes.
INDUSTRY
Biotechnology
A PRODUCT ELEDON PHARMACEUTICALS, INC. IS KNOWN FOR
Tegoprubart
Tegoprubart is an investigational anti-CD40L antibody in clinical trials for transplant rejection prevention, aiming to be a safer immunosuppressive alternative, with promising progress toward Phase 3 development.
ETFS HOLDING THIS STOCK
ETFS HOLDING
52
LISTED HERE
11
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
47.02%
HOLDERS
191
TOP 12 OF 191 · RANKED BY POSITION SIZE
Bvf Inc/Il
Blackrock, Inc.
Vanguard Group Inc
Ra Capital Management, L.P.
Goldman Sachs Group Inc
Ensign Peak Advisors, Inc
Zimmer Partners, LP
Sphera Funds Management Ltd.
Siren, L.L.C.
Geode Capital Management, LLC
Blue Owl Capital Holdings LP
Adar1 Capital Management, LLC
RATINGS SNAPSHOT
Overall rating: C
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book1
Overall Score2
INSIDER TRADES
★
DIRECTOR, OFFICER: PRESIDENT
Perrin Steven
Sale · 72.1K shares
2026-07-31
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Gros David-Alexandre C
Purchase · 354.5K shares
2026-07-31
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Gros David-Alexandre C
Sale · 194.8K shares
2026-07-31
★
DIRECTOR, OFFICER: PRESIDENT
Perrin Steven
Purchase · 152.4K shares
2026-07-31
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 2
2 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 ACHV | $8.10 | COMPARE |
 ALLO | $2.02 | COMPARE |
 EDIT | $3.16 | COMPARE |
 PBYI | $9.06 | COMPARE |
 AVIR | $5.36 | COMPARE |
 ABEO | $5.92 | COMPARE |
 VNDA | $5.29 | COMPARE |
 TRDA | $7.00 | COMPARE |